OBJECTIVES: Latent class analysis of demographic and clinical variables can help identify subtypes of patients with bipolar disorder type I (BD I). Classification of patients into clinically relevant and homogeneous subtypes may have implications for further research. We examine the structure of mood and anxiety spectrum features in patients with BD I to identify subtypes with similar profiles. METHODS: Adult patients diagnosed with BD I, who were also participants in the Bipolar Disorder Center for Pennsylvanians (BDCP) Study, were followed for a median time of 448 days. Data from self-report instruments of BD I patients were used to derive dichotomous indicators of four spectrum conditions. Latent class analysis was applied to these indicators. Demographic and clinical variables were used as external validators of the classes. RESULTS: A 3-class solution provided a satisfactory data fit and outlined three classes of subjects. Members of the three groups differed in terms of demographic and clinical variables, such as gender, age of onset, mean Clinical Global Impression (CGI) depressive ratings and overall CGI ratings at entry, weighted mean CGI ratings for the period between the first and last evaluation in the BDCP Study and mean Global Assessment of Functioning scores at entry and during the BDCP Study. CONCLUSIONS: We found substantial clinical heterogeneity among individuals with BD I and found that the levels of lifetime depressive, manic, panic-agoraphobic, and obsessive-compulsive spectrum symptoms identify three distinct subtypes characterized by differences in demographic and clinical variables. These results may have implications for research on the neurobiology, genetics, and treatment of BD I.
OBJECTIVES: Latent class analysis of demographic and clinical variables can help identify subtypes of patients with bipolar disorder type I (BD I). Classification of patients into clinically relevant and homogeneous subtypes may have implications for further research. We examine the structure of mood and anxiety spectrum features in patients with BD I to identify subtypes with similar profiles. METHODS: Adult patients diagnosed with BD I, who were also participants in the Bipolar Disorder Center for Pennsylvanians (BDCP) Study, were followed for a median time of 448 days. Data from self-report instruments of BD I patients were used to derive dichotomous indicators of four spectrum conditions. Latent class analysis was applied to these indicators. Demographic and clinical variables were used as external validators of the classes. RESULTS: A 3-class solution provided a satisfactory data fit and outlined three classes of subjects. Members of the three groups differed in terms of demographic and clinical variables, such as gender, age of onset, mean Clinical Global Impression (CGI) depressive ratings and overall CGI ratings at entry, weighted mean CGI ratings for the period between the first and last evaluation in the BDCP Study and mean Global Assessment of Functioning scores at entry and during the BDCP Study. CONCLUSIONS: We found substantial clinical heterogeneity among individuals with BD I and found that the levels of lifetime depressive, manic, panic-agoraphobic, and obsessive-compulsive spectrum symptoms identify three distinct subtypes characterized by differences in demographic and clinical variables. These results may have implications for research on the neurobiology, genetics, and treatment of BD I.
Authors: Liliana Dell'Osso; Antonella Armani; Paola Rucci; Ellen Frank; Andrea Fagiolini; Giorgio Corretti; M Katherine Shear; Victoria J Grochocinski; Jack D Maser; Jean Endicott; Giovanni B Cassano Journal: Compr Psychiatry Date: 2002 Jan-Feb Impact factor: 3.735
Authors: M W Otto; N M Simon; S R Wisniewski; D J Miklowitz; J N Kogan; N A Reilly-Harrington; E Frank; A A Nierenberg; L B Marangell; K Sagduyu; R D Weiss; S Miyahara; M E Thas; G S Sachs; M H Pollack Journal: Br J Psychiatry Date: 2006-07 Impact factor: 9.319
Authors: E Frank; M K Shear; P Rucci; J M Cyranowski; J Endicott; A Fagiolini; V J Grochocinski; P Houck; D J Kupfer; J D Maser; G B Cassano Journal: Am J Psychiatry Date: 2000-07 Impact factor: 18.112
Authors: Naomi M Simon; Michael W Otto; Stephen R Wisniewski; Mark Fossey; Kemal Sagduyu; Ellen Frank; Gary S Sachs; Andrew A Nierenberg; Michael E Thase; Mark H Pollack Journal: Am J Psychiatry Date: 2004-12 Impact factor: 18.112
Authors: Liliana Dell'Osso; Paola Rucci; Giovanni B Cassano; Jack D Maser; Jean Endicott; M Katherine Shear; Nannina Sarno; Marco Saettoni; Victoria J Grochocinski; Ellen Frank Journal: Compr Psychiatry Date: 2002 Mar-Apr Impact factor: 3.735
Authors: M K Shear; E Frank; P Rucci; D A Fagiolini; V J Grochocinski; P Houck; G B Cassano; D J Kupfer; J Endicott; J D Maser; M Mauri; S Banti Journal: J Psychiatr Res Date: 2001 Jan-Feb Impact factor: 4.791
Authors: Khrista R Boylan; Peter J Bieling; Michael Marriott; Helen Begin; L Trevor Young; Glenda M MacQueen Journal: J Clin Psychiatry Date: 2004-08 Impact factor: 4.384
Authors: Ellen Frank; Jill M Cyranowski; Paola Rucci; M Katherine Shear; Andrea Fagiolini; Michael E Thase; Giovanni B Cassano; Victoria J Grochocinski; Bryan Kostelnik; David J Kupfer Journal: Arch Gen Psychiatry Date: 2002-10
Authors: S Yen; R Stout; H Hower; M A Killam; L M Weinstock; D R Topor; D P Dickstein; J I Hunt; M K Gill; T R Goldstein; B I Goldstein; N D Ryan; M Strober; R Sala; D A Axelson; B Birmaher; M B Keller Journal: Acta Psychiatr Scand Date: 2015-10-17 Impact factor: 6.392
Authors: G B Cassano; M Mula; P Rucci; M Miniati; E Frank; D J Kupfer; A Oppo; S Calugi; L Maggi; R Gibbons; A Fagiolini Journal: J Affect Disord Date: 2008-06-09 Impact factor: 4.839
Authors: Karan S Kverno; Betty S Black; David M Blass; Jeanne Geiger-Brown; Peter V Rabins Journal: J Am Med Dir Assoc Date: 2008-07-30 Impact factor: 4.669
Authors: Meredith L Wallace; Burcin Simsek; David J Kupfer; Holly A Swartz; Andrea Fagiolini; Ellen Frank Journal: J Affect Disord Date: 2016-06-07 Impact factor: 4.839
Authors: J C Fournier; M T Keener; B C Mullin; D M Hafeman; E J Labarbara; R S Stiffler; J Almeida; D M Kronhaus; E Frank; M L Phillips Journal: Psychol Med Date: 2012-05-09 Impact factor: 7.723
Authors: G M Goodwin; P M Haddad; I N Ferrier; J K Aronson; Trh Barnes; A Cipriani; D R Coghill; S Fazel; J R Geddes; H Grunze; E A Holmes; O Howes; S Hudson; N Hunt; I Jones; I C Macmillan; H McAllister-Williams; D R Miklowitz; R Morriss; M Munafò; C Paton; B J Saharkian; Kea Saunders; Jma Sinclair; D Taylor; E Vieta; A H Young Journal: J Psychopharmacol Date: 2016-03-15 Impact factor: 4.153
Authors: E A Holmes; M B Bonsall; S A Hales; H Mitchell; F Renner; S E Blackwell; P Watson; G M Goodwin; M Di Simplicio Journal: Transl Psychiatry Date: 2016-01-26 Impact factor: 6.222